Munich, Germany

Christoph Burdack


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • München, DE (2012)
  • Munich, DE (2012 - 2015)

Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Christoph Burdack: Innovator in Cancer Therapeutics

Introduction

Christoph Burdack is a notable inventor based in Munich, Germany. He has made significant contributions to the field of cancer therapy through his innovative research and development of therapeutic compounds. With a total of 4 patents, Burdack's work focuses on creating compounds that target critical proteins involved in cancer progression.

Latest Patents

Burdack's latest patents include groundbreaking inventions such as Pyrrolidin-2-ones and Tetrahydro-isoquinolines. The Pyrrolidin-2-ones patent presents compounds that act as ligands binding to the HDM2 protein, inducing apoptosis and inhibiting proliferation. These compounds have therapeutic utility in cancer therapy and prevention. They can also be used to treat various conditions, including stroke, myocardial infarction, ischemia, multi-organ failure, spinal cord injury, Alzheimer's Disease, and heart valvular degenerative disease. Additionally, these compounds may help decrease the side effects from cytotoxic cancer agents and radiation, as well as treat viral infections. Similarly, the Tetrahydro-isoquinolines patent provides compounds that serve as ligands binding to the HDM2 protein, with similar therapeutic applications.

Career Highlights

Throughout his career, Christoph Burdack has worked with several companies, including Nexuspharma, Inc. and Priaxon AG. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical therapeutics.

Collaborations

Burdack has collaborated with notable professionals in his field, including Vladimir Khazak and Lutz Weber. These partnerships have further enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Christoph Burdack is a prominent inventor whose work in cancer therapeutics has the potential to change the landscape of treatment options available. His innovative compounds and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…